Brian P. McGlinch
Research Subjects
Brian P. McGlinch has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Darrell R. Schroeder
Mayo Clinic
2 shared publications - Juraj Sprung
Department of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA
2 shared publications - Lavonne Liedl
Mayo Clinic College of Medicine
2 shared publications - Michael L. Kendrick
Department of Surgery, Mayo Clinic, Rochester, USA
2 shared publications - Toby N. Weingarten
Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA
2 shared publications - Todd A. Kellogg
Mayo Clinic
2 shared publications
Latest Publications
- 5 September 2014
- Published by Springer Nature in Obesity Surgery
- Vol. 25 (3) , 506-513
Intranasal Nicotine Increases Postoperative Nausea and is Ineffective in Reducing Pain Following Laparoscopic Bariatric Surgery in Tobacco-Naïve Females: A Randomized, Double Blind Trial
Nicotine is a known analgesic. Our primary aim was to test the hypothesis that intranasal nicotine administered intraoperatively reduces the need for postoperative opioids. The secondary outcomes included evaluation of both postoperative pain and nausea and vomiting (PONV). Nonsmoking female patients undergoing laparoscopic bariatric operations were randomized to receive either 3 mg intranasal nicotine (N = 42) or placebo spray (N = 47) at the conclusion of surgery. Postoperative opioid use converted to intravenous morphine equivalents (iv MEQ) and PONV rates were recorded during both the recovery room postanesthesia care unit (PACU) stay and the first 24 postoperative hours. All patients received multimodal antiemetic prophylaxis. Total iv MEQ were not significantly reduced during the PACU stay in patients receiving nicotine (median [interquartile range (IQR)], 5.3 [0, 10.0] mg for nicotine vs. 5.2 [0, 12.7] mg for placebo, one-tailed P = 0.414) or for the first 24 h following PACU discharge (39.6 [20.0, 52.5] mg for nicotine vs. 32.7 [20.3, 51.3] mg for placebo, one-tailed P = 0.752). For the combined period (PACU + 24-h post-PACU discharge), iv MEQ were 45.8 [27.0, 58.6] mg for nicotine and 39.4 [23.5, 60.0] mg for placebo, one-tailed P = 0.801. Compared to placebo, a higher percentage of patients administered nicotine received antiemetics in the PACU (57.1 vs. 25.5 %, P = 0.002). Intraoperative intranasal nicotine did not exhibit opioid-sparing effect in nonsmoking bariatric female patients. Despite antiemetic prophylaxis, the use of nicotine was associated with the higher frequency of the use of rescue antiemetics in PACU.
- 5 September 2014
- Published by Springer Nature in Obesity Surgery
- Vol. 25 (3) , 506-513
Intranasal Nicotine Increases Postoperative Nausea and is Ineffective in Reducing Pain Following Laparoscopic Bariatric Surgery in Tobacco-Naïve Females: A Randomized, Double Blind Trial
Nicotine is a known analgesic. Our primary aim was to test the hypothesis that intranasal nicotine administered intraoperatively reduces the need for postoperative opioids. The secondary outcomes included evaluation of both postoperative pain and nausea and vomiting (PONV). Nonsmoking female patients undergoing laparoscopic bariatric operations were randomized to receive either 3 mg intranasal nicotine (N = 42) or placebo spray (N = 47) at the conclusion of surgery. Postoperative opioid use converted to intravenous morphine equivalents (iv MEQ) and PONV rates were recorded during both the recovery room postanesthesia care unit (PACU) stay and the first 24 postoperative hours. All patients received multimodal antiemetic prophylaxis. Total iv MEQ were not significantly reduced during the PACU stay in patients receiving nicotine (median [interquartile range (IQR)], 5.3 [0, 10.0] mg for nicotine vs. 5.2 [0, 12.7] mg for placebo, one-tailed P = 0.414) or for the first 24 h following PACU discharge (39.6 [20.0, 52.5] mg for nicotine vs. 32.7 [20.3, 51.3] mg for placebo, one-tailed P = 0.752). For the combined period (PACU + 24-h post-PACU discharge), iv MEQ were 45.8 [27.0, 58.6] mg for nicotine and 39.4 [23.5, 60.0] mg for placebo, one-tailed P = 0.801. Compared to placebo, a higher percentage of patients administered nicotine received antiemetics in the PACU (57.1 vs. 25.5 %, P = 0.002). Intraoperative intranasal nicotine did not exhibit opioid-sparing effect in nonsmoking bariatric female patients. Despite antiemetic prophylaxis, the use of nicotine was associated with the higher frequency of the use of rescue antiemetics in PACU.
- 1 October 2011
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 115 (4) , 906-907
Perioperative Anesthetic Care of the Obese Patient
Edited by Vilma E. Ortiz, M.D., and Jeanine Wiener-Kronish, M.D. New York, Informa Healthcare USA, Inc., 2010. Pages: 234. Price: $300.00.
- 1 October 2011
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 115 (4) , 906-907
Perioperative Anesthetic Care of the Obese Patient
Edited by Vilma E. Ortiz, M.D., and Jeanine Wiener-Kronish, M.D. New York, Informa Healthcare USA, Inc., 2010. Pages: 234. Price: $300.00.
- 1 October 2006
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 81 (10) , S25-S33
Perioperative Care of Patients Undergoing Bariatric Surgery
- 1 October 2006
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 81 (10) , S25-S33
Perioperative Care of Patients Undergoing Bariatric Surgery
- Open Access
- 1 August 2003
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 99 (2) , 518
NMS Clinical Manual of Anesthesia.
- 1 August 2003
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 99 (2) , 518
Open AccessNMS Clinical Manual of Anesthesia.